From Barchart:

Nvidia recently invested in a Utah-based biotech company, which is part of the ARKK fund. This move comes as the company continues to invest in AI chip stocks. The investment is seen as a significant one, as Nvidia continues to expand its presence in the healthcare and biotech sectors. The details of the investment and the potential impact on the biotech company have not been disclosed. This investment is part of Nvidia’s broader strategy to diversify its portfolio and expand into new and emerging markets.



Read more: Nvidia Just Invested $76 Billion in 1 Cathie Wood Stock